Background: Bone remodelling is a dynamic process critical for maintaining skeletal integrity. Disruptions in this balance can lead to osteoporosis, characterised by decreased bone density and increased fracture risk. The temporomandibular joint (TMJ), due to its unique anatomical and functional properties, may also undergo structural changes in systemic bone loss. This study explores cellular dynamics in bone remodelling and their impact on osteoporosis, focusing on skeletal bones and the TMJ. Methods: A cross-sectional study was conducted at Women Dental College from January 2023 to January 2024, involving 109 participants. Data were collected on demographics, clinical profiles, and bone mineral density (BMD). Histological and histopathological evaluations assessed trabecular and cortical structures, while molecular markers, including RANKL, OPG, and sclerostin, were measured. Anatomical parameters such as TMJ joint space width and condylar morphology were analysed using radiographic and histological methods. Statistical analyses identified key associations, with significance set at p < 0.05 Results: Participants over 50 years demonstrated significantly reduced BMD (p < 0.01) and higher rates of osteoporosis. Trabecular thickness, cortical porosity, and osteocyte density showed marked deterioration in osteoporotic individuals. Elevated RANKL/OPG ratios (p < 0.01) and increased sclerostin levels (p < 0.05) correlated with enhanced bone resorption and reduced bone formation. TMJ abnormalities, including narrowed joint space (p < 0.05) and osteophytes (p < 0.05), were more frequent in participants with osteoporosis. Statistical analysis revealed strong associations between age, inflammatory markers, and structural bone changes. Conclusion: This study highlights the multifactorial nature of bone remodelling, linking systemic osteoporosis to localised TMJ alterations. The findings emphasise the importance of integrating histological, molecular, and anatomical assessments to understand bone health comprehensively. Future research should explore targeted interventions to mitigate systemic and localised bone degeneration.